Found: 6
Select item for more details and to access through your institution.
The Protection Level of S-RBD SARS-CoV-2 Immunoglobulin G Antibodies Using the Chemiluminescent Immunoassay Compared to the Surrogate Virus Neutralization Test Method.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 16, p. 1776, doi. 10.3390/diagnostics14161776
- By:
- Publication type:
- Article
Accuracy of Anti-SARS-CoV-2 Antibody in Comparison with Surrogate Viral Neutralization Test in Persons Living with HIV, Systemic Lupus Erythematosus, and Chronic Kidney Disease.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 558, doi. 10.3390/vaccines12050558
- By:
- Publication type:
- Article
Antibody Response to SARS-CoV-2 Vaccination in Patients with End-Stage Kidney Disease on Hemodialysis.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1802, doi. 10.3390/vaccines11121802
- By:
- Publication type:
- Article
Anti-SARS-CoV-2 Antibody Level Is Associated with a History of COVID-19 Infection and mRNA Vaccination in Patients with Diabetes.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1424, doi. 10.3390/vaccines11091424
- By:
- Publication type:
- Article
High Levels of Anti-SARS-CoV-2 Receptor-Binding Domain (RBD) Antibodies One Year Post Booster Vaccinations among Hospital Workers in Indonesia: Was the Second Booster Needed?
- Published in:
- Vaccines, 2023, v. 11, n. 8, p. 1300, doi. 10.3390/vaccines11081300
- By:
- Publication type:
- Article
Performance of a Point-of-Care Fluorescence Immunoassay Test to Measure the Anti-Severe Acute Respiratory Syndrome Corona Virus 2 Spike, Receptor Binding Domain Antibody Level.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 24, p. 3686, doi. 10.3390/diagnostics13243686
- By:
- Publication type:
- Article